高级搜索

胰腺癌中医证治研究进展与评述

Advances and Comments on Traditional Chinese Medicine Syndrome and Treatment on Pancreatic Cancer

  • 摘要: 日益革新的癌症预防和治疗策略在多种恶性肿瘤的防治中收效显著,而胰腺癌发病率和死亡率的上升趋势仍未出现明显转机。中医证候物质基础的阐明可以为胰腺癌的多学科整合诊治添砖加瓦。湿热证是贯穿胰腺癌病程的核心证候,其重要物质基础组成是肿瘤炎性微环境,清热化湿方可以通过重塑肿瘤炎性微环境抑制胰腺癌恶性表型。临床中,联合清热化湿的综合治疗方案可以使胰腺癌患者的生存质量得到改善,生存时间显著延长。系统性炎性反应指数(SIRI)与湿热型胰腺癌细胞因子的改变密切相关,可以指导胰腺癌预后判断。未来基于SIRI的胰腺癌分型诊治有望进一步锁定清热化湿治疗的有效人群,围绕湿热证进行胰腺癌病程全周期证候演变规律相关研究将助力中医基于证候的胰腺癌精准治疗。

     

    Abstract: The advancements in innovative cancer prevention and treatment strategies have achieved remarkable results in the prevention and treatment of various malignant tumors. However, the increasing trend of incidence and mortality of pancreatic cancer (PC) has not shown a significant turnaround. The clarification of the material basis of traditional Chinese medicine (TCM) syndromes can contribute to the multidisciplinary integrated diagnosis and treatment of PC. Damp-heat syndrome is the core syndrome of patients with PC. It has a crucial material basis of inflammatory microenvironment. Formulas with heat-clearing and dampness-removing efficacies can inhibit malignant phenotypes by remodeling the tumor microenvironment. Conventional therapy plus heat-clearing and dampness-removing formulas can enhance the quality of life of patients with PC and significantly prolong their survival time. The systemic inflammatory response index (SIRI) is closely correlated with cytokine changes underlying damp-heat syndrome, and it can be used to direct PC prognosis assessment. In the future, PC diagnosis and treatment based on SIRI classification could distinguish patient subgroups that are responsive to heat-clearing and dampness-removing therapy. Taking damp-heat syndrome as the core point to explore the whole period of syndrome evolution throughout the course of PC could contribute to syndrome-based TCM precision treatment of PC.

     

/

返回文章
返回